Home

A Day Late and a Billion Dollars Short: Will the Medicines Co. Get to Keep its Patent?
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

In 2001, the Medicines Company just missed the application deadline for a patent extension for its main product, Angiomax, a blood thinner. Because of this error, the patent on the product will expire next week instead of in 2014.

And, because sales of Angiomax account for virtually all of Medicines’ revenue, the company has spent millions of dollars, and the last nine years trying to undo this error. In essence, the patent precludes the production of a comparable generic drug from being made.

According to the March 18 New York Times article, Clive A. Meanwell, Medicines’ chief executive was quoted as saying: “It’s a draconian penalty for an administrative mistake.”

  
What
Where


The company spent $4.4 million on lobbyists just in 2009, according to the Center for Responsive Politics.

Medicines appealed two times to the United States Patent and Trademark Office, then sued when the appeals were rejected. The company also hired lobbyists to try to get federal legislation passed that critics called “The Dog Ate My Homework Act” that would retroactively permit the patent office to accept the company’s late application.

On Tuesday, Judge Claude M. Hilton of the United States District Court in Alexandria, Va. ordered the patent office to reconsider the rejection of Medicines’ 2001 filing. The ruling also ordered the patent office to ensure the Angiomax patent did not expire during the reconsideration period.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




The Medicines Company says two law firms botched the application to the patent office, and is in talks with them about recovering damages, according to the same New York Times article.

The Medicines Company is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace.





 

Interesting Legal Sites You May Like


BCG FEATURED JOB

Locations:

Keyword:



Search Now

Mid-level Litigation Attorney

USA-CA-San Francisco

San Francisco office is seeking a mid-level litigation attorney with experience taking/defending dep...

Apply Now

Mid-level Litigation Attorney

USA-CA-San Francisco

San Francisco office is seeking a support attorney with some experience/familiarity with a litigatio...

Apply Now

Trust and Estate Attorney

USA-NY-New York City

Boutique trust and estate firm is seeking an attorney with 7+ years of experience. Candidate should ...

Apply Now

Business Litigator with 3-4 Years of Experience

USA-CA-El Segundo

Los Angeles office is seeking a class of 2014-2015 business litigator. Insurance coverage experience...

Apply Now

RELEVANT JOBS

Senior Paralegal

USA-NJ-Red Bank

*MUST HAVE CURRENT PARALEGAL EXPERIENCE (ZONING/ LAND USE PREFERRED) Red Bank, New Jersey law ...

Apply now

Chemistry Prosecutor

USA-MA-Boston

Cesari and McKenna, LLP is seeking a Patent Attorney with a MS or PhD in Chemistry with at least two...

Apply now

Associate - Insurance Coverage D&O Group

USA-NY-Valhalla

Defense firm seeking junior insurance coverage associate with strong analytical and writing skills f...

Apply now

Hotline & Training Managing Attorney (IMMIGRATION)

USA-NY-New York City

The Hotline & Training Services Managing Attorney will guide, develop, and supervise the Hotline sta...

Apply now

Most Popular

SEARCH IN ARCHIVE

To Top